North America Europe Pet Birds Health Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The pet bird health market covers products and services aimed at maintaining and improving the health of companion avian species, including parrots, parakeets, canaries, finches, and other popular pet birds. In North America, the market is valued at approximately $929 million in 2026, reflecting steady year-over-year expansion. The broader North America and Europe combined pet bird health segment was estimated at $509.0 million in 2023 and is projected to grow at a 7.80% CAGR from 2024 onward.

• •Market valued at approximately $929 million in North America in 2026, growing at ~8.0% year-over-year
• •Broader North America-Europe segment estimated at $509.0 million in 2023 with a 7.80% projected CAGR
• •Product scope includes avian-specific pharmaceuticals, nutritional supplements, parasiticides, and wellness diagnostics

Rising pet bird ownership across North America is a primary demand catalyst, supported by increasing urbanization and the appeal of birds as low-space, companion animals. Pet owners are shifting toward premium, avian-formulated healthcare products backed by veterinary recommendations, mirroring trends seen in the broader companion animal healthcare sector. Additionally, heightened awareness of zoonotic diseases and the importance of preventive avian healthcare, including regular wellness exams, vaccination protocols, and environmental hygiene, is expanding addressable market size.

• •Growing pet bird population and rising per-capita spending on avian healthcare
• •Veterinary endorsement of preventive care regimens driving demand for supplements, diagnostics, and therapeutics
• •Human-animal bond strengthening, with owners seeking higher-quality, species-specific health products

The market is typically segmented by product type, encompassing therapeutic drugs, nutritional and dietary supplements, parasiticides, and healthcare devices, as well as by distribution channel (veterinary clinics, retail pet stores, and e-commerce). North America dominates the combined North America and Europe market, supported by high pet ownership rates, established veterinary infrastructure, and a robust regulatory environment governing animal health products. Europe follows as the second-largest regional segment, with growth moderated by varying country-level regulatory frameworks and pet ownership cultural norms.

• •Product segments: therapeutic drugs, nutritional supplements, parasiticides, and diagnostic/healthcare devices
• •Distribution channels split between veterinary-clinic-led sales, brick-and-mortar retail, and growing e-commerce platforms
• •North America holds the largest regional share within the North America-Europe combined market, with Europe as a secondary growth region

Who are the notable companies in the industry?

The competitive structure is moderately fragmented, with a mix of large, diversified animal health corporations alongside smaller specialty manufacturers focused specifically on avian and exotic animal products. Integrated producers with broad companion-animal portfolios compete with niche specialty players that concentrate on avian-specific formulations and species-tailored delivery mechanisms. Production relies on established pharmaceutical and nutraceutical manufacturing processes, including extrusion, spray-drying, and sterile formulation, adapted for avian dosing requirements. Regional manufacturing capacity is concentrated in North America and Europe, leveraging proximity to primary markets and compliant regulatory frameworks for animal health product registration.

• •Moderately fragmented market with both diversified animal health conglomerates and avian-specialty niche producers
• •Integrated producers serve broad companion-animal portfolios while specialty firms focus on species-specific avian formulations
• •Manufacturing uses adapted pharmaceutical and nutraceutical processes (spray-drying, sterile compounding, extrusion), with capacity concentrated in North America and Europe

What are the recent trends and outlook?

The market is expected to continue its upward trajectory through the early 2030s, with consistent CAGR contributions supported by product innovation in avian nutrition, digital health monitoring tools, and expanded veterinary-service access. E-commerce distribution is gaining share as pet owners increasingly purchase supplements, medications, and wellness products online. Longer-term, greater regulatory harmonization across North American and European jurisdictions is likely to simplify product launches and market entry, further supporting category expansion.

• •Projected sustained 8%+ annual growth through 2030-2035 across multiple independent market estimates
• •Digital pet health technologies and online veterinary consultation platforms expected to drive product awareness and sales
• •Regulatory convergence and growing exotic-animal veterinary specialization anticipated to unlock further market potential